Seventh Annual Translational Stem Cell Conference

Starts

October 11, 2012

Ends

October 12, 2012

October 10-11, 2012: NYSCF’s Seventh Annual Translational Stem Cell Conference was held at The Rockefeller University in New York City.

NYSCF Conference Overview

The NYSCF conference is unique: it focuses on translational stem cell research, demonstrating the potential to advance cures for the major diseases of our time.

It is designed for all professionals with an interest in stem cell research, including physicians, researchers, clinical investigators, professors, government and health officials, postdoctoral fellows and graduate students. The panels on Tuesday are designed to reach a broader audience, including the lay public.

Confirmed Speakers and Session Chairs

Paola Arlotta, PhD
Harvard University

Stéphane Bancel, MD
ModeRNA

Helen Blau, PhD
Stanford University

Jeffrey Bluestone, PhD
University of California, San Francisco

Gil van Bokkelen, PhD
Athersys

Peter J. Coffey, DPhil
University of California, Santa Barbara

Yuval Dor, PhD
Hebrew University, Israel

Kevin C. Eggan, PhD
Harvard University

Dieter Egli, PhD
The New York Stem Cell Foundation

Paul Frenette, MD
Albert Einstein College of Medicine

Elaine Fuchs, PhD
The Rockefeller University

Samuel E. Gandy, MD, PhD
Mount Sinai School of Medicine

Matthias Von Herrath, MD
Novo Nordisk Diabetes Research Center

Danilo A. Tagle, PhD
National Center for Advancing Translational Sciences

Rudolf Jaenisch, MD
The Whitehead Institute

Gordon Keller, PhD
McEwen Center for Regenerative Medicine, Canada

Joanne Kurtzberg, MD
Duke University

Ruth Lehmann, PhD
New York University School of Medicine

Ravi Majeti, MD, PhD
Stanford University

Pratik Multani, MD, MS
Fate Therapeutics

Bernard Munos
InnoThink Center for Research in Biomedical Innovation

Scott Noggle, PhD
The New York Stem Cell Foundation

Kathrin Plath, PhD
University of California, Los Angeles

Shahin Rafii, MD
Weill Medical College of Cornell University

Lee Rubin, PhD
Harvard University

Hans R. Schöler, PhD
Max Planck Institute, Germany

Hans Snoeck, MD, PhD
Mount Sinai Medical School

Lorenz Studer, MD
Memorial Sloan-Kettering Cancer Center

Amy J. Wagers, PhD
Joslin Diabetes Center, Harvard University

Thomas Zwaka, MD
Baylor College of Medicine

2012 Conference Schedule

WEDNESDAY, OCTOBER 10, 2012
Caspary Auditorium, The Rockefeller University

1:00 – 1:10 Introduction & Welcome Remarks – Susan L. Solomon, CEO – NYSCF

ROAD TO THE CLINIC

1:10 – 2:30 Panel Discussion

Chair and Moderator
Lee Rubin, PhD – Harvard Stem Cell Institute
Panelist
Peter J. Coffey, DPhil – University of California, Santa Barbara
Pratik Multani, MD, MS – Fate Therapeutics
Mahendra S. Rao, MD, PhD – NIH Center for Regenerative Medicine
Gil van Bokkelen, PhD – Athersys

2:30 – 3:00 Break & Poster Session

REVOLUTIONIZING FUNCTIONAL HUMAN GENETICS

3:00 – 4:30 Panel Discussion

Chair and Moderator
Michael Manganiello –HCM Strategist
Panelist
Kevin C. Eggan, PhD – The New York Stem Cell Foundation, Harvard Stem Cell Institute
Alex Meissner, PhD – Broad Institute
Bernard Munos – InnoThink Center for Research in Biomedical Innovation
Susan L. Solomon – The New York Stem Cell Foundation
Danilo A. Tagle, PhD – National Center for Advancing Translational Sciences

4:30 – 5:30 Break & Poster Session

PROGRAMMING AND REPROGRAMMING

Chair: Ruth Lehmann, PhD – New York University School of Medicine

5:30 – 5:50 Hans R. Scholer, PhD – Max Planck Institute, Germany.
Induction of Multipotency and Pluripotency.

5:55 – 6:15 Kathrin Plath, PhD – University of California, Los Angeles.
Insights Into the Mechanism of Reprogramming to Pluripotency.

6:20 – 6:40 Thomas Zwaka, MD –Baylor College of Medicine.
The Strange Case of Plutipotentiality: Embryonic Stem Cells, Germs and Genomic Conflicts.

6:40 – 7:05 The 2012 NYSCF — Robertson Stem Cell Prize Recipient Address

THURSDAY, OCTOBER 11, 2012
Caspary Auditorium, The Rockefeller University

8:15 – 8:45 Registration and Complimentary Breakfast

8:45 – 8:50 Introduction: Susan L. Solomon, CEO, The New York Stem Cell Foundation.

8:50 – 8:55 Morning Welcome – Lee Goldman, MD, MPH, Columbia University

CANCER AND BLOOD DISEASE

Chair: Paul Frenette, MD – Albert Einstein College of Medicine

9:00 – 9:20 Elaine Fuchs, PhD – The Rockefeller University.
Stem Cells and Cancer in the Skin

9:25 – 9:45 Ravi Majeti, MD, PhD – Stanford University.
Clonal Evolution of Pre-leukemic Hematopoietic Stem Cells Preceds Human Acute Myeloid Leukemia.

9:50 – 10:10 Joanne Kurtzberg, MD – Duke University.
Traditional and Novel Applications of Cord Blood in Transplantation and Regenerative Medicine.

10:15 – 10:45 Break & Poster Session

DIABETES AND AUTOIMMUNITY

Chair: Hans Snoeck, MD, PhD – Columbia University

10:45 – 11:05 Dieter Egli, PhD – The New York Stem Cell Foundation
Advancing Health Worldwide.

11:10 – 11:30 Yuval Dor, PhD – Hebrew University, Israel.
Metabolic Control of Pancreatic Beta Cell Replication and Survival.

11:35 – 11:55 Matthias Von Herrath, MD – Novo Nordisk Diabetes Research Center.
Pathogenesis and Treatment of Human Type I Diabetes.

12:00 – 1:25 Complimentary Lunch & Poster Session

1:25 – 1:30 Afternoon Welcome – Laurie Glimcher, MD
Weill Medical College of Cornell University

1:30 – 2:00 Keynote Address I – Shahin Rafii, MD – Weill Medical College of Cornell University

HEART AND MUSCLES

Chair: Shahin Rafii, MD – Weill Medical College of Cornell University

2:05 –2:25 Gordon Keller, PhD – McEwen Center for Regenerative Medicine, Canada.
Modeling Human Hematopoietic and Cardiovascular Development with Human Pluripotent Stem Cells

2:30 – 2:50 Amy J. Wagers, PhD – Joslin Diabetes Center, Harvard University.
Aging and Rejuvenation of Tissue Stem Cells.

2:55 – 3:15 Helen Blau, PhD –Stanford University School of Medicine.
Manipulating Muslce Stem Fate in Artificial Niches

3:15 – 3:45 Break & Poster Sessions

NEURODEGENERATION AND SPINAL CORD INJURY

Chair: Sam Gandy, MD, PhD – Mount Sinai School of Medicine

3:45 – 4:05 Lorenz Studer, MD – Memorial Sloan Kettering Cancer Center.
Pluripotent Stem Cells for Dopamine Neuron Replacement in Parkinson’s Disease – Where do we Stand?

4:10 – 4:30 Paola Arlotta, PhD – Harvard University.
Molecular Development and Regeneration of Corticospinal Motor Neurons

4:30 – 5:00 Keynote Address II – Rudolf Jaenisch, MD – The Whitehead Institute

5:00PM CLOSING RECEPTION

Selected posters will be on display throughout the conference.